-- Three major investors called for a spinoff of Smith & Nephew's struggling orthopaedics business after the British medical device maker last month cut its full-year guidance, the Financial Times reports.
-- Some investors said a private equity firm could potentially acquire the company's largest but slowest growing of its three divisions, according to the FT.
-- A Smith & Nephew spokeswoman said that operational fixes and sharper commercial execution were in place, including in U.S. Orthopaedics where knee and hip implants have returned to growth.
Full story: https://on.ft.com/3AK4E0v
Write to Helena Smolak at helena.smolak@wsj.com
(END) Dow Jones Newswires
November 14, 2024 03:34 ET (08:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments